Surgeon General David Satcher announced a year-long effort to develop a national action plan for reducing the prevalence of obesity in the United States. Satcher said the process would be inclusive and collaborative, and would include open public comment periods, listening sessions, federal and non-federal dialogue, interactive workshops, and the formation of working groups to implement strategies.
Surgeon General David Satcher announced a year-long effort to develop a national action plan for reducing the prevalence of obesity in the United States. Satcher said the process would be inclusive and collaborative, and would include open public comment periods, listening sessions, federal and non-federal dialogue, interactive workshops, and the formation of working groups to implement strategies.
"The prevalence of overweight and obesity has nearly doubled among children and adolescents since 1980," Satcher told public health and industry leaders attending an international nutrition conference. "It is also increasing in both genders and among all population groups of adults. We want to establish strategies and set priorities so that we can successfully implement obesity prevention efforts that focus on the family and community, schools, work sites, the healthcare delivery system and the media."
Several follow-up events will continue efforts to develop a national action plan. An invitational, interactive workshop to further develop strategies and stimulate collaboration is in the planning stages. A meeting of federal agencies will begin dialogue to develop a coordinated federal approach. Further opportunity for public input in development of the plan is envisioned during 2001.
Obesity substantially raises the risk of illness from high blood pressure, high cholesterol, type 2 diabetes, heart disease and stroke, gallbladder disease, arthritis, sleep disturbances and breathing problems, and certain types of cancer. On average, higher body weights are associated with higher death rates. The number of overweight children, adolescents and adults has risen over the past four decades. Total costs (medical costs and lost productivity) attributable to obesity alone amounted to an estimated $99 billion in 1995. PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Seeking Sustainable Solutions: Can Passion and Profit Coexist in Pharma ESG Efforts?
October 15th 2024Industry leaders gather to discuss different ways life sciences organizations can champion their environmentally-conscious younger employees while combatting still-entrenched public mistrust.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.